Institutional Ownership Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO). We have compiled data on the 298 institutions that hold shares in the stock, with a total of 91.4 Million shares, which have been reported (via 13F filing form) to have a value of $4.96 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Dec 15, 2025 Q3 2025 |
338,500
shares
|
$18.3 Million
0.06% of portfolio
|
Q3 2025
Reduced 12.42%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
335,678
shares
|
$18.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 83.46%
|
|
|
University Of Wisconsin Foundation
Madison, WI |
Nov 14, 2025 Q3 2025 |
328,504
shares
|
$17.8 Million
13.21% of portfolio
|
Q1 2025
Reduced 20.0%
|
|
|
Jain Global LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
325,132
shares
|
$17.6 Million
0.08% of portfolio
|
Q3 2025
Reduced 5.86%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
324,630
shares
|
$17.6 Million
0.13% of portfolio
|
Q2 2025
Reduced 40.84%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
303,814
shares
|
$16.5 Million
0.09% of portfolio
|
Q3 2025
Added 115.0%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
291,593
shares
|
$15.8 Million
0.0% of portfolio
|
Q3 2025
Added 6.64%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
288,970
shares
|
$15.7 Million
0.0% of portfolio
|
Q3 2025
Reduced 13.06%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
248,079
shares
|
$13.4 Million
0.99% of portfolio
|
Q3 2025
Reduced 6.8%
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Nov 14, 2025 Q3 2025 |
244,900
shares
|
$13.3 Million
4.49% of portfolio
|
Q2 2025
Reduced 32.9%
|
|
|
Readystate Asset Management LP
Chicago, IL |
Nov 07, 2025 Q3 2025 |
237,908
shares
|
$12.9 Million
0.48% of portfolio
|
Q3 2025
Reduced 62.88%
|
|
|
B Group, Inc.
Dallas, TX |
Nov 14, 2025 Q3 2025 |
232,446
shares
|
$12.6 Million
8.12% of portfolio
|
Q2 2025
Reduced 4.15%
|
|
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
Nov 13, 2025 Q3 2025 |
230,600
shares
|
$12.5 Million
1.28% of portfolio
|
Q3 2025
Added 16.7%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 12, 2025 Q3 2025 |
228,884
shares
|
$12.4 Million
10.88% of portfolio
|
Q1 2025
Reduced 33.41%
|
|
|
Eagle Health Investments LP
Greenwich, CT |
Nov 07, 2025 Q3 2025 |
226,400
shares
|
$12.3 Million
2.86% of portfolio
|
Q1 2025
New holding
|
|
|
Schroder Investment Management Group
London, X0 |
Nov 12, 2025 Q3 2025 |
215,372
shares
|
$11.7 Million
0.01% of portfolio
|
Q3 2025
Added 44.13%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 13, 2025 Q3 2025 |
207,692
shares
|
$11.3 Million
0.02% of portfolio
|
Q3 2025
Added 33.96%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2025 Q3 2025 |
206,854
shares
|
$11.2 Million
1.54% of portfolio
|
Q3 2025
Reduced 5.98%
|
|
|
Emerald Advisers, LLC
|
Oct 30, 2025 Q3 2025 |
206,771
shares
|
$11.2 Million
0.34% of portfolio
|
Q3 2025
Reduced 29.11%
|
|
|
Yiheng Capital Management, L.P.
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
191,076
shares
|
$10.4 Million
2.39% of portfolio
|
Q3 2025
Reduced 36.26%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
189,194
shares
|
$10.3 Million
0.01% of portfolio
|
Q3 2025
Added 40.21%
|
|
|
Td Asset Management Inc
|
Nov 10, 2025 Q3 2025 |
188,844
shares
|
$10.2 Million
0.01% of portfolio
|
Q3 2025
Reduced 1.36%
|
|
|
Center Book Partners LP
Greenwich, CT |
Nov 07, 2025 Q3 2025 |
185,559
shares
|
$10.1 Million
0.48% of portfolio
|
Q3 2025
New holding
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
180,016
shares
|
$9.76 Million
0.09% of portfolio
|
Q3 2025
New holding
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Nov 14, 2025 Q3 2025 |
178,549
shares
|
$9.68 Million
0.11% of portfolio
|
Q3 2025
New holding
|
|